IL179300A0
(en )
2007-03-08
Novel-antigen-binding polypeptides and their uses
EP1731506A4
(en )
2009-12-09
5-hydroxyindole-3-carboxylates derivatives and their use
EP1848920A4
(en )
2010-06-30
Lighting system and method and reflector for use in same
PL1839182T3
(en )
2017-08-31
Use of configurations in device with multiple configurations
SG155260A1
(en )
2009-09-30
Antibodies against human interleukin-13 and uses therefor
IL176923A0
(en )
2006-12-10
Structured materials and methods
IL178277A0
(en )
2006-12-31
Irta-5 antibodies and their uses
IL181670A0
(en )
2007-07-04
Substituted phenylaminothiazoles and use thereof
EP1784608A4
(en )
2014-04-30
Cryogenic pipeline configurations and methods
IL179497A0
(en )
2011-08-01
Carboranylporphyrins and uses thereof
IL189252A0
(en )
2008-08-07
Dihydroxyanthraquinones and their use
EP1737565A4
(en )
2010-11-03
Cos-claus configurations and methods
IL184062A0
(en )
2007-10-31
Visco-supplement composition and methods
IL180365A0
(en )
2007-06-03
Carboranylporphyrins and uses thereof
HK1097495A1
(en )
2007-06-29
Can body and can
GB0406835D0
(en )
2004-04-28
Improvements in and relating to implants
GB0424552D0
(en )
2004-12-08
Methods and means
GB0403847D0
(en )
2004-03-24
Methods and means
PL366675A1
(en )
2005-10-03
Shapes for use in lighting fittings and for construction purposes
GB2423575B8
(en )
2010-03-03
Improvements in and relating to determining and/ormonitoring
ZA200706038B
(en )
2008-12-31
Visco-supplement composition and methods
EP1812032A4
(en )
2009-09-02
Tissue factor composition and methods
ZA200702281B
(en )
2009-08-26
IRTA-4 antibodies and their uses
GB0421911D0
(en )
2004-11-03
Methods and means
GB0505908D0
(en )
2005-04-27
Antibodies and their use in therapy